CM-Path Chairperson, Professor David Harrison
David Harrison MD, DSc, FRCPath, FRCPEd, FRCSEd graduated from the University of Edinburgh and trained as a histopathologist. Whilst clinically specialising in liver and kidney, his research interests are broader, coming under the general banner of systems biology and AI applied to pathology. He is currently Professor of Pathology in St Andrews, and Director of Development for Laboratory Medicine in NHS Lothian. David holds honorary chairs in Glasgow, Florida, Edinburgh, the last of these where he was Professor of Pathology for 12 years and Director of the Edinburgh Cancer Research Centre. Alongside his clinical and academic work, David is director in several small biotech companies, he chairs the UK Committee on Carcinogenicity and is Chairperson of a number of Charities. He is Director of iCAIRD (Industrial Centre for AI Research in Digital Diagnostics), a Scotland-wide consortium funded by Innovate UK.
CM-Path Executive Group
Work of the CM-Path initiative is overseen by an Executive Group, in order to maintain a strategic view and ensure delivery of its objectives. The Executive Group will ensure information-sharing and promote collaboration between Workstreams. It will seek opportunities to promote cellular molecular pathology, where appropriate, as a key component of oncology research.
Professor Louise Jones, Workstream 1 Lead
Dr Abeer Shaaban, Workstream 2 Lead
Professor Gareth Thomas, Workstream 3 Lead
Professor Clare Verrill, Workstream 4 Lead
Dr Bridget Wilkins, Royal College of Pathologists Representative
Professor Mark Arends, Pathological Society Representative
Dr Ian Lewis, NCRI Representative
Dr Rowena Sharpe, CRUK, Funder Representative
Dr Raffaella Tate, Consumer Representative
Dr Matthew Hobbs, Prostate Cancer UK, Funder Representative